TITLE

Sunitinib treatment in a patient with metastatic renal cell carcinoma and bariatric surgery

AUTHOR(S)
van Kinschot, Caroline; Erp, Nielka; Feberwee, Tanja; Dezentjé, Vincent
PUB. DATE
October 2015
SOURCE
European Journal of Clinical Pharmacology;Oct2015, Vol. 71 Issue 10, p1279
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented on metastatic renal cell carcinoma patient treated with sunitinib.
ACCESSION #
109345397

 

Related Articles

  • Discontinuation of the Tyrosine Kinase Inhibitor Sunitinib in Patients with Metastatic Renal Cell Carcinoma: A Case Series. Neuhaus, Thomas; Luyken, Joachim; Stier, Sebastian // Urology Journal;Mar/Apr2014, Vol. 11 Issue 2, p1494 

    Purpose: Tyrosine kinase inhibitors (TKI) play a pivotal role in the modern treatment of patients with metastatic renal cell carcinoma (mRCC). Depending on the course and the response, the targeted therapy may last for years. Thus the question arises, if a successful treatment leading to a...

  • A Phase I Study of Temsirolimus and Bryostatin-1 in Patients With Metastatic Renal Cell Carcinoma and Soft Tissue Sarcoma. Plimack, Elizabeth R.; Tan, Tingting; Wong, Yu‐Ning; Mehren, Margaret M.; Malizzia, Lois; Roethke, Susan K.; Litwin, Samuel; Li, Tianyu; Hudes, Gary R.; Haas, Naomi B. // Oncologist;2014, Vol. 19 Issue 4, p354 

    Background. Temsirolimus, an inhibitor of mammalian target of rapamycin (mTOR) complex 1, is approved for the treatment of metastatic renal cell carcinoma (RCC). Bryostatin-1 inhibits protein kinase C, a downstream effector of mTOR complex 2. We observed antitumor effects with the combination of...

  • ONCOLOGY. Megumi Ng // Journal of Pharmacy Practice & Research;Dec2013, Vol. 43 Issue 4, p328 

    The article reviews published research in oncology. On the use of tivozanib for the treatment of metastatic renal cell carcinoma (RCC), tivozamib use showed higher occurence of hypertension. On the use of brivanib for advanced hepatocellular carcinoma (HCC) findings showed that overall survival...

  • F-Fluoride PET/CT in the detection of bone metastases in clear cell renal cell carcinoma: discordance with bone scintigraphy. Fuccio, Chiara; Spinapolice, Elena; Cavalli, Carla; Palumbo, Raffaella; D'Ambrosio, Daniela; Trifirò, Giuseppe // European Journal of Nuclear Medicine & Molecular Imaging;Dec2013, Vol. 40 Issue 12, p1930 

    The article presents a case study of the use of 18F-fluoride Positron Emission Tomography-Computed Tomography (PET/CT) for detecting bone metastasis in patients with clear cell renal cell carcinoma (RCC). In the given patient, PET/CT showed multiple pathological bone lesions including the...

  • Indium-111 Capromab Pendetide (ProstaScint®) Demonstrates Renal Cell Carcinoma and Aortocaval Nodal Metastases from Prostate Adenocarcinoma. Rizvi, Tanvir; Deng, Chunli; Rehm, Patrice K. // World Journal of Nuclear Medicine;Sep2015, Vol. 14 Issue 3, p209 

    A 62-year-old male with a history of radical prostatectomy for a Gleason 9 (4 + 5) pT3N0Mx prostate cancer presented with rising prostate-specific antigen of 9.0 ng/dl. A contrast-enhanced computerized tomography (CT) revealed an enhancing left upper pole renal mass and aortocaval lymph nodes....

  • Renal cell carcinoma presenting as recurrence in vastus intermedius after 22 years of long-term disease free survival: A rare metastatic presentation. Qamar Wani, Shaqul; Khan, Talib; Yamin Wani, Saiful; Rasool Malik, Tariq; Manzoor Najmi, Arshad; Raiq Mir, Liza; Ashraf Teli, Mohammad; Maqbool Lone, Mohammad; Afroz, Fir; Ahmad Khan, Nazir // Clinical Cancer Investigation Journal;Jan/Feb2016, Vol. 5 Issue 1, p34 

    Renal cell carcinoma (RCC) has widespread and unpredictable metastatic potential, even when the curative nephrectomy is performed. RCC can metastasize via venous and lymphatic routes virtually to any site but commonly metastasizes to lungs, lymph nodes, bones, liver, and brain. Muscular...

  • Angiotensin System Inhibitors Extend Survival in Patients With Metastatic Renal Cell Carcinoma.  // Personalized Medicine in Oncology;Apr2014, Vol. 3 Issue 2, p114 

    No abstract available.

  • Targeted therapy for metastatic renal cell cancer in older patients.  // British Journal of Hospital Medicine (17508460);Apr2011, Vol. 72 Issue 4, p190 

    The article discusses a study by H. Khambati, T.K. Choueiri, C.K. Kollmannsberger and colleagues to examine the efficacy of targeted therapy for metastatic renal cell carcinoma in older population. The data analysis of patients treated with first-line antivascular endothelial growth factor...

  • Metastatic Renal Cell Carcinoma: An Unusual Cause of Bleeding Pancreatic Mass. GAJENDRA, SMEETA; SACHDEV, RITESH; MOHAPATRA, ISHANI; GOEL, RUCHIKA; GOEL, SHALINI // Journal of Clinical & Diagnostic Research;Sep2015, Vol. 9 Issue 9, p15 

    Renal Cell Carcinoma metastasizing to pancreas is uncommon, occurring in 1-2% of cases; lung being the most common site. It is usually asymptomatic, or may present as abdominal pain, weight loss, pancreatitis or gastrointestinal bleeding. Herein, we present a case of 75-year-old male presented...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics